Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8922478 | Clinical and Translational Radiation Oncology | 2017 | 6 Pages |
Abstract
SBRT for extracranial MM exhibited improved MF compared with CHRT, consistent with intracranial radiosurgery data. Though these data are retrospective and subject to selection bias, our findings support the prudent use of SBRT in a select group of favorable, oligometastatic MM patients, and should be discussed as an alternative to surgery and ablation.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ryan S. Youland, Miran L. Blanchard, Roxanna Dronca, Lisa Kottschade, Svetomir N. Markovic, Kenneth R. Olivier, Sean S. Park,